AgeAccelPheno
3 papers1 finding
- Humans3
Effects
1Dementia
no changein humans1HR 1.01
1 study
Dementia
no changein humans1HR 1.01
AgeAccelPheno has no effect on dementia in humans (HR 1.01, 95% CI 0.95-1.07).
“and 1.01 (0.95-1.07; p = 0.74) for AgeAccelPheno. Only AgeAccelGrim2 remained significant under the Bonferroni-corrected threshold for significance (p < 0.02).”
Humansper one-standard deviation incrementmedian follow-up of 9.3 yearsfemalesn = 6,069
Aging cell21 Feb 2026
Latest
6 in 12 monthsJournal of Alzheimer's Disease
Sex-specific accelerated epigenetic aging in the Alzheimer's disease spectrum
Cohort study of 143 peopleEpigenetic age
AAIC 2025 Abstract
Prospective associations of epigenetic age estimators with Alzheimer's disease atrophy patterns among older women: The Women's Health Initiative Memory Study
Cohort study of 1,196 peopleAlzheimer's disease
AAIC 2025 Abstract
Do epigenetic age‐acceleration estimators predict survival to age 90 with preserved cognition? The Women's Health Initiative Memory Study (WHIMS)
Cohort study of 5,293 peopleGrimAge
Alzheimer's & Dementia
Epigenetic clocks and longitudinal plasma biomarkers of Alzheimer's disease
Cohort study of 2,366 peopleAlzheimer's disease
medRxiv
Epigenetic clocks of biological aging and risk of incident mild cognitive impairment and dementia: the Women's Health Initiative Memory Study
Preprint: cohort study of 6,069 peopleMild cognitive impairment
Journal of Affective Disorders
Accelerated epigenetic aging in males with mood disorders accompanied by insomnia
Case-control study in peopleGrimAge